Companies / NovoCure Ltd
NovoCure Ltd
Nasdaq: NVCRCIK 1645113ST. HELIER
Insider flow · last 90 daysNet sells $185.8K
Financials · FY2025
Ownership
116.4M shares outstanding · as of Jul 17, 2026
Ownership
| Institutions | 81.48% | 94,875,298 |
| Public float | 18.52% | 21,570,542 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Ben Arye BarakFormerGeneral Counsel | — | — |
Brackmann ChristophChief Financial Officer | — | — |
Cordova AshleyCEOFormer Chief Executive Officer | — | — |
Danziger AsafDirector | — | — |
Doyle William FExecutive Chairman · Director | — | — |
Hilleman Jeryl LDirector | — | — |
Hung DavidDirector | — | — |
Leonard Frank XCEOFormerChief Executive Officer | — | — |
Leung GabrielDirector | — | — |
Leupin NicolasFormerFormer Chief Medical Officer | — | — |
Institutional holders 247
View all →| Holder | Value | % of shares |
|---|---|---|
| $217.18M | 14.42% | |
| $203.22M | 11.52% | |
| $141.69M | 9.41% | |
| $110.30M | 7.33% | |
| $65.55M | 4.35% | |
| $43.43M | 2.46% | |
| $27.38M | 2.16% | |
| $25.99M | 1.73% | |
| $16.91M | 1.33% | |
| $16.46M | 1.09% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-6.05M | -555K -85.89% | 91,215 0.08% of shares | medium |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $5.06M | +464K +190.20% | 708,293 0.61% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $4.38M | +289K +11.23% | 2,866,546 2.46% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common stock | $-3.35M | -307K -87.14% | 45,318 0.04% of shares | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-3.21M | -180K -39.16% | 279,912 0.24% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $2.39M | +134K +48.01% | 414,291 0.36% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | Common stock | $-2.06M | -136K -43.24% | 178,287 0.15% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $2.05M | +131K +40.76% | 453,705 0.39% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Soleus Capital Master Fund, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NVCR | — | G6674U108 |